The MiniMed Go™ system is cleared for individuals with insulin-requiring type 1 and type 2 diabetes aged 7 years and older, ...

Multiple bills that were signed into law this year are set to take effect in 2026. The changes span from addressing insulin prices, to college admission regulations and to plastic bag laws. Here is a ...

Starting in 2026, Californians will be able to buy prescription insulin pens for $11. Through CalRx and a partnership with manufacturers, Californians will be able to buy discounted insulin from the ...

NEW YORK — Federal prosecutors said CVS Pharmacy will pay $37.76 million to resolve accusations that the company repeatedly dispensed more insulin to patients than their prescriptions required and ...

Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes had a higher time in range if they usually administered bolus insulin after a missed ...

The settlement resolves allegations that, from 2010 through 2020, CVS violated the False Claims Act in connection with its billing and dispensing of insulin pens to patients enrolled in government ...

CVS Pharmacy agreed to pay $37.7 million to settle a lawsuit with the United States over a decade-long practice of over-dispensing insulin to customers and then seeking undue reimbursements from ...

CVS reached a settlement on Tuesday with the U.S. Attorney for the Southern District of New York for over $37.75 million after the retailer was accused of over-dispensing insulin pens to patients.

CVS has agreed to pay almost $38 million to settle allegations that its pharmacies overcharged the government for insulin pens over a decade, putting to bed a Department of Justice lawsuit and several ...

CVS Health (CVS) has reached a settlement with the U.S. government, requiring the company to pay $37.76M to resolve claims that it overbilled government healthcare programs for insulin pens. The ...

NEW YORK, Dec 2 (Reuters) - CVS Health (CVS.N), opens new tab will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained improper reimbursements ...